Provider profile
Kymos.
Bioanalytical services
Kymos describes GLP/GCP bioanalysis for preclinical and clinical studies (Phase I–IV): PK/TK, biomarker, immunogenicity and cell-based assays on LC-MS/MS, ligand-binding and qPCR platforms, for small molecules, peptides, oligonucleotides, nucleic acids, antibodies and other biologics. It lists bioanalytical laboratories in Cerdanyola del Vallès (headquarters) and Frankfurt, and a CMC testing site in Italy.
- Website
- kymos.com (opens in a new tab)
- Sources reviewed
- November 4, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
Development experience
Development experience
Development stage
Locations
Locations
- Cerdanyola del Vallès, Spain · Headquarters10
- Hørsholm, Denmark · Laboratory5Listed as the Denmark site (Hørsholm address); services at this site are not described on reviewed pages
- Frankfurt, Germany · Laboratory11Kymos Germany (Prolytic GmbH): GLP-certified site with bioanalysis of small molecules, large molecules and nucleic acids
- Monsano, Italy · Laboratory12Kymos Italy (Pharmaprogress): GMP QC/stability testing lab; no bioanalysis stated
- Seoul, South Korea · Office5
- Cerdanyola del Vallès, Spain · Laboratory10Listed by the company as its main lab in Barcelona; laboratories include bioanalysis of small and large molecules
Quality and regulatory
Quality and regulatory
The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Whether a validated method already exists for your molecule or a close analogue, and who owns it
- Validation scope against ICH M10 for your assay type, and expected timeline
- Current instrument and analyst capacity, and turnaround per sample batch
- Sample receipt, storage conditions, chain of custody and international shipping experience
- Most recent regulatory inspection or audit outcomes relevant to your studies
- Data-integrity controls and the format of data delivered to your PK or biometrics vendor
Evidence and sources
Evidence and sources
- 1Bioanalysis of biological drugs and biosimilars - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2GLP Bioanalysis of small molecules & generics | Kymos Group (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Biomarker Analysis Services - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4GLP-certified quantification of Nucleic Acids - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Bioanalytical and CMC Services - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6GMP Certified Laboratory: Quality Assurance & Compliance (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7CMC Analysis & Quality Control | Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8Validation and Method Development - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Quality control of small molecules - Kymos (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 10Kymos in Barcelona - CRO for Bioanalysis and CMC (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 11Prolytic - Bioanalysis and Pharmacokinetics (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 12Pharmaprogress - Quality Control and Stability Studies (opens in a new tab)Kymos · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.